Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0022-5347(02)80355-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Autologous Fascial Pubovaginal Sling for Recurrent Stress Incontinence: A Retrospective Study.
Low Urin Tract Symptoms
January 2025
Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Aim: This study aimed to analyze the clinical efficacy and safety of autologous fascial pubovaginal sling (AFPVS) surgery in treating recurrent stress urinary incontinence (SUI) following the failure of mid-urethral sling procedures.
Methods: A retrospective analysis was conducted on the clinical data of SUI patients who underwent AFPVS at our hospital between 2008 June and 2024 June following the failure of mid-urethral sling procedures. The analysis included basic information, surgical parameters, and postoperative complications.
Evaluation and Management of Female Stress Urinary Incontinence.
Mayo Clin Proc
November 2024
Department of Urology, Mayo Clinic, Rochester, MN; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN. Electronic address:
Article Synopsis
- Female stress urinary incontinence is a common issue where urine leaks during activities that increase abdominal pressure, and it can significantly affect a woman's quality of life.
- Diagnosis typically involves looking at the patient's history and physical exam, particularly noting any urine leakage during specific actions like coughing.
- Treatment options vary widely, including conservative methods (like observation and pelvic floor therapy) and surgical procedures, with decisions made collaboratively between the patient and physician based on individual needs and conditions.
Managing female stress urinary incontinence in a post mesh era: What to do and when to refer.
Aust J Gen Pract
May 2024
MBBS, MS, FRACS (Urol), Urologist, Department of Urology, Royal Melbourne Hospital, Melbourne, Vic; Urologist, Epworth Healthcare, Melbourne, Vic.
Article Synopsis
- Urinary incontinence, particularly stress urinary incontinence (SUI), is a common issue in primary care that can greatly impact a patient's daily life and requires effective assessment and management by healthcare providers.
- The diagnosis of SUI is typically based on the patient's medical history and specific physical exams, with pelvic floor physiotherapy and lifestyle changes as primary treatment options.
- For more severe cases, surgical solutions like urethral bulking agents and different types of slings are available, with synthetic mid-urethral slings remaining a popular choice for treating SUI in women.
Effect of lower urinary tract conditions on surgical outcomes of different suburethral sling procedures for female stress urinary incontinence.
Int Urol Nephrol
September 2024
Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung-Yang Road, Hualien, Taiwan.
Article Synopsis
- - The study compares the long-term outcomes and complications of two surgical treatments for female stress urinary incontinence: retropubic pubovaginal sling (PVS) and transobturator tape (TOT) from 2010 to 2022.
- - Results showed a higher success rate for PVS (87.4%) compared to TOT (75.4%). Additionally, the TOT group experienced more persistent overactive bladder symptoms and required repeat procedures more often.
- - The findings suggest that TOT procedures are less effective than PVS, with no significant differences in success rates based on bladder function or pressure measurements.
Cosmetic and functional impact of fascia lata harvest for use in surgery for stress urinary incontinence.
Neurourol Urodyn
June 2024
Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Article Synopsis
- The study examines patient perceptions of the functional and cosmetic impact of fascia lata harvesting for the treatment of stress urinary incontinence (SUI) after the FDA's ban on transvaginal mesh.
- A survey was conducted among 72 eligible patients who had the procedure between 2017 and 2022, with a 40.3% response rate yielding insights into symptoms and satisfaction levels.
- Results show that most patients were satisfied with both the appearance of the harvest site scar and the improvement in their SUI, with less than 25% reporting any significant discomfort or symptoms related to the harvest site.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!